– UK – Byotrol plc, the leading AIM listed anti-microbial hygiene company, today announces the appointment of Dr Trevor Francis to its board as Chief Technology Officer with immediate effect.
Dr Francis has been working as a consultant to the Company in various positions over the last six years, particularly in consumer product development and commercialisation. Prior to joining Byotrol, Dr Francis spent 29 years at Unilever where he became Vice President of the Global R&D Homecare division and Head of the European Fabric Conditioners & Global Fragrance divisions.
Dr Francis is also a board trustee of the Liverpool School of Tropical Medicine where he serves on the Audit and Remuneration Committees.
Commenting on the appointment, Nicholas Martel, Chairman of Byotrol, said: “We are delighted to welcome Trevor to the Board. His proven experience of delivering innovative products to market will be invaluable as we seek to consolidate on the recent improvements made within the Company.”
About Byotrol Plc
Byotrol plc (BYOT.L), quoted on AIM, is a leading anti-microbial technology company, operating globally in the Food, Industrial, Healthcare and Consumer sectors, providing low toxicity products with a broad-based and long-lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, mycobacteria and algae.
Powerful, long-lasting and gentle, Byotrol’s products can be used stand alone or as an ingredient within existing products, where Byotrol can significantly improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.
Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives for everyone.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.